Atricure Inc
ATRC
Get informed when a big investor buys or sells
+ FollowCurrent Fair Value
67.3% upsideUndervalued by 67.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.40 Billion |
|---|---|
| Enterprise Value | $1.34 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.24 |
| Beta | 1.28 |
| Outstanding Shares | 48,334,000 |
Return
| Return on Equity | -0.93% |
|---|---|
| Return on Assets | -0.71% |
| Return on Invested Capital | -1.96% |
Valuation & Multiples
| P/E Ratio | -291.18 |
|---|---|
| PEG | 286.6 |
| Price to Sales | 2.38 |
| Price to Book Ratio | 2.62 |
| Enterprise Value to Revenue | 2.43 |
| Enterprise Value to EBIT | -119.96 |
| Enterprise Value to Net Income | -292 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.17 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Next Earnings Call
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 9,800▼ 69.85% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 104.74%▲ 2.66% |
|---|---|
| Total Invested | $1.46B▼ 24.17% |
| Investors Holding | 221▼ 13.00% |
ESG Score
No data
About Atricure Inc
Relevant Senate Committees
This powerful committee controls taxation, trade, and entitlement spending (Medicare/Medicaid). Medicare reimbursement policies are a critical factor for the revenue and profitability of medical device companies.
This committee directly allocates federal spending to agencies like the FDA and NIH, and to government healthcare programs (e.g., VA, Medicare), profoundly impacting Atricure's regulatory environment and market demand.
This committee directly oversees the FDA, which is the primary regulatory body for medical device approval and market access, and the NIH, which funds crucial medical research.
This committee's oversight of intellectual property (patents for medical devices) and antitrust laws (M&A) is critically important for an innovative manufacturing company like Atricure.
The Department of Veterans Affairs is a significant purchaser of medical devices and supplies. Funding decisions by this committee directly impact government healthcare contractors like Atricure.